DocGo Inc. Line of Credit, Current
DocGo Inc. (DCGO) had Line of Credit, Current of $0 as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:LinesOfCreditCurrent · last filed 2026-03-16
- 2025-12-31: Line of Credit, Current $0.00.
- 2025-09-30: Line of Credit, Current $0.00.
- 2025-06-30: Line of Credit, Current $30.00M.
- 2025-03-31: Line of Credit, Current $30.00M.
| Period end | Line of Credit, Current | Line of Credit, Current as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-16 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $30.00M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $30.00M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $30.00M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $30.00M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $30.00M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $30.00M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $25.00M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $696.05K 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $696.31K 10-Q · filed 2023-08-08 | |
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 | $664.91K 10-Q · filed 2023-08-08 |
| 2022-09-30 | $1.03M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.03M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.03M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $25.88K 10-K · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |